GDF15 and COVID-19: Since studies are scarce, it is imperative to continue research on this topic with larger patient cohorts to fully understand the potential of GDF-15 as a biomarker of COVID-19 severity and to recognize its pathophysiological pathways in this disease, as well as in others.